Extended red blood cell matching for all transfusion recipients is feasible

Joost H. J. van Sambeeck, C. Ellen van der Schoot, Nico M. van Dijk, Henk Schonewille, Mart P. Janssen

Research output: Contribution to journalArticle*Academicpeer-review

Abstract

Objective: To demonstrate the feasibility and effectiveness of extended matching of red blood cells (RBC) in practice. Background: At present, alloimmunisation preventing matching strategies are only applied for specific transfusion recipient groups and include a limited number of RBC antigens. The general assumption is that providing fully matched RBC units to all transfusion recipients is not feasible. In this article we refute this assumption and compute the proportion of alloimmunisation that can be prevented, when all donors and transfusion recipients are typed for A, B, D plus twelve minor blood group antigens (C, c, E, e, K, Fya, Fyb, Jka, Jkb, M, S and s). Methods: We developed a mathematical model that determines the optimal sequence for antigen matching. The model allows for various matching strategies, issuing policies and inventory sizes. Results: For a dynamic inventory composition (accounting for randomness in the phenotypes supplied and requested) and an antigen identical issuing policy 97% and 94% of alloimmunisation events can be prevented, when respectively one and two RBC units per recipient are requested from an inventory of 1000 units. Although this proportion decreases with smaller inventory sizes, even for an inventory of 60 units almost 50% of all alloimmunisation events can be prevented. Conclusion: In case antigen of both donors and recipients are comprehensively typed, extended preventive matching is feasible for all transfusion recipients in practice and will significantly reduce transfusion-induced alloimmunisation and (alloantibody-induced) haemolytic transfusion reactions.
Original languageEnglish
JournalTransfusion medicine (Oxford, England)
Early online date2021
DOIs
Publication statusE-pub ahead of print - 2021

Keywords

  • alloimmunisation prevention
  • extended antigen matching
  • red cell genotyping

Cite this